News

Indoco Remedies Limited announced that its Committee of Executive Directors has approved the incorporation of a wholly owned subsidiary, Warren Lifesciences Private Limited, for which name approval has been received from the Registrar of Companies, Mumbai. The new company, to be incorporated in India, will operate in the pharmaceutical sector and intends to manufacture, develop, and sell pharmaceutical products including active pharmaceutical ingredients, finished formulations, and key starting materials, with Indoco Remedies Limited holding 100% shareholding and an authorized and paid-up equity share capital of Rs 1,00,000 divided into 10,000 equity shares of Rs 10 each.

Indoco Remedies Limited announced it executed a deed of conveyance on August 27, 2026, to sell a plot of land measuring approximately 2,876.08 square meters to Kalpataru Townships Private Limited for Rs 64,00,00,000. The company stated the sale will not impact its business operations and does not constitute a substantial undertaking, and that no related parties are involved.

Indoco Remedies Limited has fixed Thursday, September 10, 2026, as the record date for determining entitlement to a final dividend of Rs 0.20 per equity share for the financial year ended March 31, 2026, subject to shareholder approval at the Annual General Meeting scheduled for September 17, 2026; the company’s register of members and share transfer books will remain closed from September 11, 2026, to September 17, 2026, and Thursday, September 10, 2026, is also the cut-off date for remote e-voting and e-voting during the AGM.

Net profit of Indoco Remedies reported to Rs 64.99 crore in the quarter ended June 2026 as against net loss of Rs 35.79 crore during the previous quarter ended June 2025. Sales rose 8.21% to Rs 466.22 crore in the quarter ended June 2026 as against Rs 430.86 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales466.22430.86 8 OPM %8.804.07 - PBDT14.91-6.96 LP PBT-19.62-36.66 46 NP64.99-35.79 LP Powered by Capital Market - Live News

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 28 July 2026.